iFR Assessment of Intermediate Aortic Stenosis Lesions Consolidates

Once a big void that prevented us from effectively assessing functional compromise, intermediate aortic stenosis has made us treat many lesions “just in case”, to save us what would be a complicated procedure, had a valve been placed. Auspiciously, some light has been shed by several, most welcome, studies simultaneously published in J Am Coll Cardiol Intv.

iFR en lesiones no culpables: el momento de la medición parece cambiar la historiaThis study looked at 95 consecutive patients with severe aortic stenosis and intermediate coronary lesions in 116 vessels. It compared invasive iFR with FFR values and non-invasive adenosine stress myocardial perfusion imaging.  

 

Mean iFR was 0.86 (0.76 to 0.93) and FFR was 0.84 (0.76 to 0.91). According to authors, iFR values showed good correlation with FFR values. However, these figures have different clinical implications, seeing as they have different cutoff values. The authors adjusted iFR cut off value to 0.82, but considered standard an FFR cutoff value of ≤0.75. The latter used to be the original value, the one in the DEFER study, one that has been replaced by 0.8 since the FAME trials.


Read also: Safety of Lesion Deferral with iFR or FFR in Both Stable and Acute Patients.


FFR and iFR values also correlated well with perfusion values.

 

Conclusion

According to this study, iFR, FFR, and stress adenosine prefusion values correlate well in patients with severe aortic stenosis. However, this could be misleading: there was no assessment after procedure to check whether values had changed. In this context, rather than changing cutoff index values, it would be easier to measure with iFR alone, since it is not affected by stenosis, compared to FFR which tends to underestimate severity.

 

Original title: Instantaneous Wave-Free Ratio for the Assessment of Intermediate Coronary Artery Stenosis in Patients with Severe Aortic Valve Stenosis. Comparison With Myocardial Perfusion Scintigraphy.

Reference: Futoshi Yamanaka et al.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...